Joseph N. Blattman

Arizona State University — United States

Immunology and Microbiology · Life Sciences

35h-index12.7kcitations97works1.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immune Cell Function and Interaction(46), T-cell and B-cell Immunology(42), Immunotherapy and Immune Responses(42), CAR-T cell therapy research(23), Cancer Immunotherapy and Biomarkers(12)

Publications97 total

Microbiome depletion reduces Immune Checkpoint Blockade (ICB) efficacy in a Murine Metastatic Osteosarcoma (mOS) model 4501
The Journal of Immunology·2025Open Access
Harnessing the microbiome to improve clinical outcomes for cancer, transplant, and immunocompromised patients in the intensive care unit (ICU)
Frontiers in Cellular and Infection Microbiology·2025· 3 citedOpen Access
Engaging Undergraduate Students in Course-based Research Improved Student Learning of Course Material.
PubMed·2024· 2 citedOpen Access
Abstract 2191 Unveiling the Target: Investigating the Protective Potential of EnsembleMHC-Predicted T-Cell Epitopes against Metastatic Osteosarcoma
Journal of Biological Chemistry·2024Open Access
The impact of microbiome dysbiosis on T cell function within the tumor microenvironment (TME)
Frontiers in Cell and Developmental Biology·2023· 13 citedOpen Access
Flow Cytometry Analysis of Immune Cell Responses
Methods in molecular biology·2022· 5 cited
Identifying Key Differences Between Responders vs. Non-Responders to Immune Checkpoint Blockade for Metastatic Osteosarcoma (mOS)
The Journal of Immunology·2022
Rexinoids Modulate Effector T Cell Expression of Mucosal Homing Markers CCR9 and α4β7 Integrin and Direct Their Migration In Vitro
Frontiers in Immunology·2022· 6 citedOpen Access
Systemic Delivery of mLIGHT-Armed Myxoma Virus Is Therapeutic for Later-Stage Syngeneic Murine Lung Metastatic Osteosarcoma
Cancers·2022· 9 citedOpen Access
Systemic delivery of TNF-armed myxoma virus plus immune checkpoint inhibitor eliminates lung metastatic mouse osteosarcoma
Molecular Therapy — Oncolytics·2021· 34 citedOpen Access
A Macro-scale Comparison Algorithm for Analysis of TCR Repertoire Completeness
2021Open Access
Modeling Immunopathology During Persistent Viral Infections
2021
Selection influences naive CD8+ TCR‐β repertoire sharing
Immunology·2020· 1 citedOpen Access
Addition of rexinoids during T cell activation enhances mucosal-homing receptor expression and migratory ability of effector cells <i>in vitro</i>
The Journal of Immunology·2020
Mechanism of T cell mediated hemorrhagic disease during LCMV infection
The Journal of Immunology·2020
The Impact of Broadly Relevant Novel Discoveries on Student Project Ownership in a Traditional Lab Course Turned CURE
CBE—Life Sciences Education·2019· 72 citedOpen Access
Corrigendum to “A heterologous prime-boosting strategy with replicating Vaccinia virus vectors and plant-produced HIV-1 Gag/dgp41 virus-like particles” [Virology 507 (2017) 242–256]
Virology·2019
Novel Vaccine Adjuvants: Exploring the Potential of Rexinoids to Influence Effector T Cell Homing to Mucosal Sites
The Journal of Immunology·2019
Intracellular pairing of multiple mRNA species at the single-cell level using DNA Origami
The Journal of Immunology·2019
Characterizing unconventional T cells in the tumor microenvironment of metastatic osteosarcoma
The Journal of Immunology·2019
page 1 of 5Next →

Frequent Co-authors

Philip D. Greenberg(16), Rafi Ahmed(14), E. John Wherry(9), Megan S. McAfee(7), Kaja Murali‐Krishna(6), Susan M. Kaech(5), Danielle M. Lussier(5), David Sourdive(4), Pooja Hingorani(4), Lizbeth M. Nieves(4), Sang‐Jun Ha(3), Daniel L. Barber(3), John D. Altman(3), Robbert van der Most(3), Rustom Antia(3), John L. Johnson(3), Susan Holechek(3), Ingunn M. Stromnes(3), Nicole Appel(3), Jacquelyn Kilbourne(3)